Increased cerebral blood flow during m-CPP exacerbation of obsessive-compulsive disorder

Area of Science:

• Neuroscience
• Psychiatry
• Medical Imaging

Background:

• Obsessive-compulsive disorder (OCD) is a mental health condition characterized by intrusive thoughts and repetitive behaviors.
• The drug m-chlorophenyl-piperazine (m-CPP), a partial serotonin agonist, has been observed to exacerbate OCD symptoms in some individuals.
• The physiological basis for this variable response to m-CPP in OCD patients remains unclear.

Purpose of the Study:

• To investigate the physiological mechanisms underlying the variable exacerbation of obsessive-compulsive disorder (OCD) symptoms by m-chlorophenyl-piperazine (m-CPP).
• To examine the relationship between m-CPP administration and regional cerebral blood flow in patients with OCD.

Main Methods:

• Regional cerebral blood flow was measured using the planar xenon-133 method.
• Oral administration of m-CPP (0.5 mg/kg) was given to participants.
• Participants were divided into two groups: those who showed symptomatic exacerbation (responders) and those who did not (non-responders).

Main Results:

• Patients who responded to m-CPP with worsened OCD symptoms exhibited a significant increase in global cortical perfusion (18.1%).
• Patients who did not respond to m-CPP showed no significant change in global cortical perfusion.
• These findings indicate a physiological difference between responders and non-responders.

Conclusions:

• The exacerbation of obsessive-compulsive disorder symptoms by m-CPP is associated with increased cortical blood flow.
• This suggests that altered cerebral blood flow patterns may play a role in the variable response to serotonergic agents in OCD.
• Further research into neurovascular mechanisms in OCD is warranted.